NCT02068898View on ClinicalTrials.gov

Pharmacokinetic Comparison of XS003 and Tasigna

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

May 31, 2014

Conditions
Healthy
Interventions
DRUG

XS003

DRUG

Tasigna

Trial Locations (1)

NG11 6JS

Quotient Clinical, Nottingham

All Listed Sponsors
lead

XSpray Microparticles

INDUSTRY

NCT02068898 - Pharmacokinetic Comparison of XS003 and Tasigna | Biotech Hunter | Biotech Hunter